We evaluated the expression of PARP-1 in a prostate cancer TMA with normal prostate tissue (n = 6), prostate hyperplasia (n = 7), and prostatic adenocarcinoma (n = 94) graded based on Gleason score ranging from 6 to 10. Here, PARP1 is linked to benign prostatic hyperplasia.